Advocacy & Compliance

Healthesystems’ Advocacy & Compliance experts are essential in the management of pharmacy and ancillary benefits for our clients. By tracking and influencing regulatory activity, our team stays ahead of evolving trends and identifies opportunities to advocate on behalf of our clients, their injured workers, and the broader industry.

Go to Regulatory Recap News

Subscribe for Weekly Updates

The Advocacy &  Compliance Team

Monitors and reports on proposed and pending regulatory changes that impact workers' comp, helping shape effective program strategies

Advocates for fair and balanced public policy through proactive engagement with regulators, customers, and other stakeholders throughout the rulemaking lifecycle

Supports operational compliance by providing guidance to internal stakeholders and external partners during the implementation of new regulatory changes

Regulatory Recap

A weekly e-newsletter informed by the Advocacy & Compliance team to help keep our clients and industry contacts in the know on the latest legislation and policy updates impacting workers’ comp.

Subscribe

Presumptions

Florida May Increase Cancer Benefits to Firefighters With $25,000 Payment

Additionally, benefits may be extended for up to 10 years post-employment.

Read More →

January 12, 2026

Mental Health Presumptions

Kentucky Could Make Psychological Injuries Compensable for First Responders

If enacted, House Bill 26 would apply to police officers, firefighters, emergency medical services personnel, and members of the National Guard.

Read More →

January 12, 2026

Presumptions

Virginia Considers Expanding Cancer Presumptions to Sheriffs

Exceptions to the presumption are made for certain cancers diagnosed prior to key dates.

Read More →

January 12, 2026

Access to Care

Washington State May Allow PTs and OTs to Qualify as Attending Providers

If enacted, physical therapists and occupational therapists could direct care for injured workers.

Read More →

January 12, 2026

Marijuana

White House Issues Executive Order to Reschedule Marijuana

Rescheduling marijuana to Schedule III will allow for greater clinical research, possible FDA-approved drugs, and more.

Read More →

December 22, 2025

Advocacy Opportunity Claim Data

Texas Seeks Feedback On 2026 Medical Audit Plan

Stakeholder input could determine if the audit focuses on either topical analgesics or utilization review compliance.

Read More →

December 22, 2025

Presumptions

States Consider Expanding Presumptions

Illinois, Pennsylvania, and Washington seek to expand current presumptions to additional occupations.

Read More →

December 22, 2025

Technology

AI Oversight Bills

Florida, Pennsylvania, and New Hampshire are open to AI in claims management, but would require humans to have the final say.

Read More →

December 22, 2025

Worker Safety

OSHA Issues Seven Letters of Interpretation for Workplace Safety and Health Requirements

These letters provide official explanations of agency requirements and how they apply to workplace situations and hazardous conditions.

Read More →

December 15, 2025

« Previous 1 … 15 16 17 18 19 … 56 Next »

Subscribe to Regulatory Recap

Get weekly legislation & policy updates straight to your inbox.

hello world!

Further resources you may be interested in

Additional articles and updates from Healthesystems related to policy shaping workers’ comp.

More States Continue with PTSD Legislation

Oklahoma and Rhode Island enact new presumptions, with Georgia adding extra coverage.

Maryland and Arizona Enact New Psychedelic Laws

A Maryland taskforce will plan regulation, while Arizona will tentatively cover MDMA treatment for first responders with PTSD.

Positive Marijuana Screenings Increase – What More to Expect with Rescheduling?

New data from Quest Diagnostics 2024 Drug Testing Index, and industry leaders discuss how rescheduling will impact workers’ comp.

Physician Dispensing Concerns in Workers’ Compensation

Physician dispensing represents an ongoing challenge for today’s workers’ comp payers – not only from a cost perspective, but from clinical and safety perspectives.